Dr Steven Coca on Biomarkers to Identify Patients at Risk of Developing CKD After Acute Kidney Injury
There is great value, both for clinical trials and clinical practice, in biomarkers that identify patients at greatest risk of developing chronic kidney disease (CKD) after acute kidney injury, explained Steven Coca, DO, MS, Icahn School of Medicine at Mount Sinai.